Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)
Status: | Completed |
---|---|
Conditions: | Other Indications, Cosmetic, Cosmetic |
Therapuetic Areas: | Dermatology / Plastic Surgery, Other |
Healthy: | No |
Age Range: | 35 - 65 |
Updated: | 1/11/2019 |
Start Date: | June 30, 2014 |
End Date: | May 3, 2015 |
A study to evaluate patient satisfaction, aesthetic and psychological impact of combined
treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS
XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).
treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS
XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).
Inclusion Criteria:
- Qualified to receive treatment with BOTOX® Cosmetic, a facial filler (JUVÉDERM® ULTRA
XC and/or JUVÉDERM® ULTRA Plus XC and/or JUVÉDERM® VOLUMA® XC) and LATISSE® treatment
- Naïve to botulinum toxin therapy of any serotype for any indication
- Naïve to prescription eyelash growth products of any type
- Naïve to dermal filler treatment in the face and neck
Exclusion Criteria:
- Undergone facial plastic surgery, tissue grafting, tissue augmentation or facial
dermal filler injections
- Had laser, photomodulation, intense pulsed light, radio frequency, dermabrasion or
chemical peel in the face or neck
- Have received skin resurfacing (laser, photomodulation, intense pulsed light, radio
frequency, dermabrasion, chemical peel, or non-ablative procedures) in the face or
neck within 3 months
- Systemic retinoid therapy within 1 year prior to study enrollment
- Presence of inflammation at the proposed injection site(s)
- Profound atrophy/excessive weakness of muscles in target areas of injection
- Known immunization or hypersensitivity to any botulinum toxin serotype
- Undergone oral surgery or dental procedures within 30 days
- No visible eyelashes
- Use of permanent eyeliner, eyelash implants, semi-permanent eyelash tint, dye or
extension
- Use of prescription eyelash growth products
- Unwilling or unable to remove contact lenses prior to study medication application in
the evening and keep lenses out for 30 minutes
- Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, amyotrophic lateral sclerosis,
or any other disease that might interfere with neuromuscular function.
We found this trial at
1
site
Click here to add this to my saved trials